Zurich Cantonal Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.46M | Sell |
|
|||||
|
2025
Q2 | $8.58M | Sell |
|
|||||
|
2025
Q1 | $12.7M | Buy |
|
|||||
|
2024
Q4 | $8.36M | Buy |
|
|||||
|
2024
Q3 | $7.02M | Sell |
|
|||||
|
2024
Q2 | $12.4M | Buy |
|
|||||
|
2024
Q1 | $8.8M | Buy |
|
|||||
|
2023
Q4 | $5.92M | Buy |
|
|||||
|
2023
Q3 | $2.22M | Sell |
|
|||||
|
2023
Q2 | $1.89M | Buy |
|
|||||
|
2023
Q1 | $2.03M | Buy |
|
|||||
|
2022
Q4 | $2.38M | Sell |
|
|||||
|
2022
Q3 | $2.2M | Buy |
|
|||||
|
2022
Q2 | $1.93M | Buy |
|
|||||
|
2022
Q1 | $1.7M | Sell |
|
|||||
|
2021
Q4 | $1.55M | Sell |
|
|||||
|
2021
Q3 | $1.93M | Sell |
|
|||||
|
2021
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q1 | $1.95M | Buy |
|
|||||
|
2020
Q4 | $1.44M | Sell |
|
|||||
|
2020
Q3 | $2.62M | Buy |
|
|||||
|
2020
Q2 | $2.71M | Buy |
|
|||||
|
2020
Q1 | $1.64M | Buy |
|
|||||
|
2019
Q4 | $1.92M | Buy |
|
|||||
|
2019
Q3 | $518K | Buy |
|
|||||
|
2019
Q2 | $443K | Hold |
|
|||||
|
2019
Q1 | $462K | Sell |
|
|||||
|
2018
Q4 | $437K | Buy |
|
|||||
|
2018
Q3 | $697K | Buy |
|
|||||
|
2018
Q2 | $541K | Buy |
|
|||||
|
2018
Q1 | $428K | Sell |
|
|||||
|
2017
Q4 | $458K | Buy |
|
|||||
|
2017
Q3 | $288K | Buy |
|
|||||
|
2017
Q2 | $143K | Sell |
|
|||||
|
2017
Q1 | $188K | Sell |
|
|||||
|
2016
Q4 | $307K | Hold |
|
|||||
|
2016
Q3 | $402K | Buy |
|
|||||
|
2016
Q2 | $109K | Hold |
|
|||||
|
2016
Q1 | $95K | Hold |
|
|||||
|
2015
Q4 | $136K | Buy |
|
|||||
|
2015
Q3 | $44K | Buy |
|
|||||
|
2015
Q2 | $18K | Hold |
|
|||||
|
2015
Q1 | $15K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $668K | Hold |
|
|||||
|
2014
Q1 | $725K | Hold |
|
|||||
|
2013
Q4 | $420K | Hold |
|
|||||
|
2013
Q3 | $509K | Buy |
|